Overview

The Medical Research Future Fund Act 2015 was enacted to establish the Medical Research Future Fund, aimed at improving the health and wellbeing of Australians by providing grants for medical research and medical innovation. This Act was introduced to address the need for a dedicated fund to support future medical research initiatives and was enacted by the Parliament of Australia. The policy objective of the Act is clearly stated as improving health outcomes through sustained financial support for medical research. The Medical Research Future Fund (Crediting of Amounts) Determination 2016 (No. 1) was made under the authority of the Treasurer and the Minister for Finance to credit a specific amount to the Medical Research Future Fund Special Account, reflecting savings and residual funds from other health-related initiatives. This determination, which is a legislative instrument but not subject to disallowance, ensures the timely allocation of funds to the newly established Medical Research Future Fund.

Scope and Application

The Medical Research Future Fund (Crediting of Amounts) Determination 2016 (No. 1) applies to the responsible Ministers who are tasked with determining the crediting of specific amounts to the Medical Research Future Fund Special Account as outlined in the Medical Research Future Fund Act 2015. This Act establishes the Fund with the objective of improving the health and wellbeing of Australians through grants supporting medical research and innovation. The fund is intended to benefit the broader Australian community, with a focus on advancing medical research and innovation. The crediting of the specified amount of $1,277,358,332.00, sourced from savings in the Health portfolio and residual amounts from the closure of the Health and Hospitals Fund, is mandated by this determination. Geographically, this Act has a Commonwealth reach, impacting federal legislative processes and financial transactions. The determination does not specify any exclusions, exemptions, or thresholds beyond the amount to be credited on the specified date. Additionally, the Act indicates that while the determination is a legislative instrument under the Legislation Act 2003, it is not subject to disallowance under that Act.

Key Provisions

The Medical Research Future Fund (Crediting of Amounts) Determination 2016 (No. 1) is a legislative instrument under section 15(1)(a) of the Medical Research Future Fund Act 2015, which mandates that a specified sum be credited to the Medical Research Future Fund Special Account on a specified date. Specifically, this determination requires the crediting of $1,277,358,332.00 to the Fund on 26 August 2016. This amount comprises savings from the Health portfolio and residual funds from the closure of the Health and Hospitals Fund. The responsible Ministers made this determination in writing, in alignment with section 15(2) of the Act, which stipulates that such determinations must consider the object of the Act, namely, to improve the health and wellbeing of Australians through the provision of grants for medical research and innovation. The determination imposes clear obligations on the responsible Ministers, requiring them to credit the specified amount to the Fund on the designated date. It is essential that this process adheres to the legislative framework established by the Medical Research Future Fund Act 2015. The Act ensures that the funds are managed in accordance with the overarching objective of enhancing health outcomes through medical research and innovation. The responsible Ministers must ensure that the crediting is executed precisely as stipulated, thereby facilitating the Fund’s ability to disburse grants as intended. Breaches of the requirements set out in this determination could potentially lead to legal repercussions, although the Act does not explicitly outline specific penalties for non-compliance in this context. The determination itself is not subject to disallowance under section 42 of the Legislation Act 2003, which means that once made and registered, it becomes legally effective without the need for parliamentary approval. However, the failure to credit the specified amount on the designated date could be viewed as a deviation from the legislative mandate, potentially leading to scrutiny or other administrative consequences. The absence of explicit penalties in the Act suggests that the primary consequence of non-compliance would be the inability to meet the legislative objectives, thereby impacting the Fund's capacity to support medical research and innovation.